India vs Singapore: Proportion of isolates with resistance to azithromycin reported to
India
12.5
in 2020
Singapore
12.9
in 2020
India rank
15th
Singapore rank
14th
Proportion of isolates with resistance to azithromycin reported to over time
- India
- Singapore
How they compare
Singapore currently reports 12.9 against 12.5 in India, a difference of 0.4.
The two have swapped places 1 time across 6 shared years of data; in 2014 it was India ahead.
India ranks 15th and Singapore ranks 14th of 47 countries.
Across the 2 decades both report, India averaged higher in 1 and Singapore in 1.
Head to head by decade
| Decade | India | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 7.27 | 2.28 | 4.99 | India |
| 2020s | 12.5 | 12.9 | 0.4 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with resistance to azithromycin reported to, India or Singapore?
- Singapore, at 12.9 against 12.5 in India as of 2020.
- What is the difference in proportion of isolates with resistance to azithromycin reported to between India and Singapore?
- 0.4, with Singapore ahead.
- How many years of comparable data are there for India and Singapore?
- 6 years are reported by both, from 2014 to 2020.
- How do India and Singapore rank globally for proportion of isolates with resistance to azithromycin reported to?
- India ranks 15th and Singapore ranks 14th of 47 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.